Scarica l'app Stockscreener
76.08
3.30%
2.43
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché NUVL Giù?
Forum
Previsione
Nuvalent Inc Borsa (NUVL) Ultime notizie
Regression Model Predicts Rangebound Movement in Nuvalent Inc.2025 Pullback Review & Momentum Based Trading Signals - classian.co.kr
Nuvalent Announces Positive Pivotal Data for Zidesamtinib in Lung Cancer - MSN
Piper Sandler initiates coverage of oncology companies (CGON:NASDAQ) - Seeking Alpha
Piper Sandler initiates Nuvalent stock coverage with Overweight rating - Investing.com
Is Nuvalent Inc. showing insider buying2025 EndofYear Setup & Stepwise Entry and Exit Trade Signals - newsimpact.co.kr
Nuvalent Inc. Hits Oversold Level on RSI Indicator2025 Key Highlights & Real-Time Sentiment Analysis - metal.it
Is Nuvalent Inc. stock a buy or sellJuly 2025 Weekly Recap & Community Driven Trade Alerts - mustnews.co.kr
Is Nuvalent Inc. in a bullish channel2025 Bull vs Bear & Stepwise Entry/Exit Trade Alerts - thegnnews.com
Heatmap Data Shows High Activity in Nuvalent Inc. Sector2025 Price Action Summary & Daily Stock Trend Reports - 선데이타임즈
Is Nuvalent Inc. stock overvalued or fairly pricedTrade Exit Summary & Free AI Powered Buy and Sell Recommendations - classian.co.kr
Nuvalent’s SWOT analysis: oncology innovator’s stock faces pivotal year By Investing.com - Investing.com Nigeria
Nuvalent’s SWOT analysis: oncology innovator’s stock faces pivotal year - Investing.com
Inhibrx Awaits Ozekibart Clinical Data in October - AInvest
Nuvalent to Present Pivotal Data from ARROS-1 Clinical Trial of Zidesamtinib for TKI Pre-treated Patients with Advanced ROS1-positive NSCLC at WCLC 2025 Presidential Symposium - The Malaysian Reserve
Nuvalent to present pivotal lung cancer drug data at WCLC 2025 - Investing.com Nigeria
J.P. Morgan Analyst Keeps Buy Rating on Nuvalent with $111 Price Target - AInvest
How Nuvalent Inc. stock performs during market volatilityTop Fast Growth Opportunities - thegnnews.com
Can Nuvalent Inc. navigate macro headwindsWeekly Investment Watchlist - sisain.net
Quant Strategy Flags Nuvalent Inc. for EntryShort Term Buy Zone Stock Alerts Signal Entry - metal.it
Nuvalent Reports Q2 2025 Financials and Pipeline Progress - TipRanks
Nuvalent’s Promising Developments and Strong Financial Position Justify Buy Rating - TipRanks
Nuvalent’s Promising Drug Pipeline and Strategic Trials Drive Buy Rating - TipRanks
Nuvalent Reports Q2 2025 Financial Results and Highlights Pipeline Progress - AInvest
Nuvalent's Q2 Net Loss Widens - MarketScreener
Nuvalent's 2025 Momentum: Catalysts, Commercial Readiness, and Cash Runway Positioning for a Breakout Year - AInvest
Nuvalent (NUVL) Q2 R&D Up 65% - The Motley Fool
Nuvalent initiates rolling NDA submission for ROS1-positive NSCLC drug By Investing.com - Investing.com Australia
Nuvalent initiates rolling NDA submission for ROS1-positive NSCLC drug - Investing.com India
Earnings Flash (NUVL) Nuvalent Posts Q2 Net Loss Per Share $1.39, vs. FactSet Est of $1.22 - MarketScreener
Nuvalent, Inc. SEC 10-Q Report - TradingView
Nuvalent Highlights Pipeline and Business Achievements, Reiterates Key Anticipated Milestones, and Reports Second Quarter 2025 Financial Results - MarketScreener
Nuvalent's Dual Victory: FDA Rolling Review for ROS1 Cancer Drug While Phase 3 Trial Advances New ALK Treatment - Stock Titan
Analysts' Bullish Sentiments on Healthcare Companies: Avantor, Nuvalent, and Alphatec Holdings - AInvest
Analysts Offer Insights on Healthcare Companies: Avantor (AVTR), Nuvalent (NUVL) and Alphatec Holdings (ATEC) - The Globe and Mail
What catalysts could drive Nuvalent Inc. stock higher in 2025Build wealth faster with consistent growth stocks - Jammu Links News
What makes Nuvalent Inc. stock price move sharplyInvest confidently with professional market insights - Jammu Links News
Is Nuvalent Inc. a growth stock or a value stockExceptional financial outcomes - Jammu Links News
How volatile is Nuvalent Inc. stock compared to the marketInvest confidently with real-time data - Jammu Links News
What is the dividend policy of Nuvalent Inc. stockDynamic investment growth - Jammu Links News
How many analysts rate Nuvalent Inc. as a “Buy”Achieve breakthrough investment performance - Jammu Links News
What institutional investors are buying Nuvalent Inc. stockFind the best stocks for sustainable growth - Jammu Links News
What is the risk reward ratio of investing in Nuvalent Inc. stockGet ahead with breakthrough trading ideas - Jammu Links News
Published on: 2025-08-03 06:27:04 - Jammu Links News
Nuvalent’s Noci sells $321k in shares By Investing.com - Investing.com Australia
Nuvalent’s Noci sells $321k in shares - Investing.com India
0.94%
1.72%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):